{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:48:34Z","timestamp":1786996114869,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.radonc.2022.05.004","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T04:13:51Z","timestamp":1652242431000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Utilization of the lymph node-to-primary tumor ratio of PET standardized uptake value and circulating Epstein\u2013Barr virus DNA to predict distant metastasis in nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"177","author":[{"given":"Eric Yi-Liang","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Min","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Din-Li","family":"Tsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Ming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Jan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiang-Fu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Lung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason Chia-Hsun","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Joy","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Hsing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Tung-Chieh","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2022.05.004_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2022.05.004_b0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2022.05.004_b0015","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.ijrobp.2005.05.042","article-title":"Nasopharyngeal carcinoma with cranial nerve palsy: The importance of MRI for radiotherapy","volume":"63","author":"Chang","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.004_b0020","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ijrobp.2004.09.057","article-title":"Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography","volume":"62","author":"Chang","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.004_b0025","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.radonc.2013.10.020","article-title":"Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities","volume":"110","author":"Sun","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.05.004_b0030","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1200\/JCO.2015.60.9347","article-title":"Management of nasopharyngeal carcinoma: Current practice and future perspective","volume":"33","author":"Lee","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.05.004_b0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.critrevonc.2017.03.030","article-title":"Palliative systemic therapy for recurrent or metastatic nasopharyngeal carcinoma \u2013 how far have we achieved?","volume":"114","author":"Lee","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.radonc.2022.05.004_b0040","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv291","article-title":"Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma","volume":"108","author":"Tang","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2022.05.004_b0045","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1056\/NEJMoa032260","article-title":"Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma","volume":"350","author":"Lin","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2022.05.004_b0050","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/cncr.11496","article-title":"Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type","volume":"98","author":"Leung","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2022.05.004_b0055","doi-asserted-by":"crossref","first-page":"53217","DOI":"10.18632\/oncotarget.10676","article-title":"Correlation between overall survival and differential plasma and tissue tumor marker expression in nasopharyngeal carcinoma patients with different sites of organ metastasis","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2022.05.004_b0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2967\/jnumed.111.090696","article-title":"Prognostic significance of 18F-FDG PET parameters and plasma Epstein-Barr virus DNA load in patients with nasopharyngeal carcinoma","volume":"53","author":"Chang","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2022.05.004_b0065","doi-asserted-by":"crossref","first-page":"38296","DOI":"10.18632\/oncotarget.5699","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2022.05.004_b0070","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-6106-2","article-title":"Maximal standard uptake values of 18F-fluoro-2-deoxy-d-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients","volume":"19","author":"Sun","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2022.05.004_b0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4048\/jbc.2015.18.2.173","article-title":"Axillary lymph node-to-primary tumor standard uptake value ratio on preoperative 18F-FDG PET\/CT: A prognostic factor for invasive ductal breast cancer","volume":"18","author":"Kim","year":"2015","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.radonc.2022.05.004_b0080","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3390\/cancers12030607","article-title":"Prognostic value of lymph node-to-primary tumor standardized uptake value ratio in esophageal squamous cell carcinoma treated with definitive chemoradiotherapy","volume":"12","author":"Lin","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2022.05.004_b0085","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1186\/s12885-020-07044-4","article-title":"Prognostic value of lymph node to primary tumor standardized uptake value ratio in unresectable esophageal cancer","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2022.05.004_b0090","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1007\/s00259-017-3729-x","article-title":"Prognostic importance of lymph node-to-primary tumor standardized uptake value ratio in invasive squamous cell carcinoma of uterine cervix","volume":"44","author":"Chung","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2022.05.004_b0095","doi-asserted-by":"crossref","first-page":"104756","DOI":"10.1016\/j.oraloncology.2020.104756","article-title":"Lymph node-to-primary tumor standardized uptake value ratio on PET predicts distant metastasis in nasopharyngeal carcinoma","volume":"110","author":"Hung","year":"2020","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2022.05.004_b0100","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1158\/1078-0432.CCR-12-3702","article-title":"An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma","volume":"19","author":"Le","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2022.05.004_b0105","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hed.21890","article-title":"Plasma Epstein-Barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma","volume":"34","author":"Hsu","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2022.05.004_b0110","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s00259-018-4172-3","article-title":"Value of early evaluation of treatment response using 18F-FDG PET\/CT parameters and the Epstein-Barr virus DNA load for prediction of outcome in patients with primary nasopharyngeal carcinoma","volume":"46","author":"Chen","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2022.05.004_b0115","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.3390\/cancers13143555","article-title":"Intensity modulated proton beam therapy versus volumetric modulated arc therapy for patients with nasopharyngeal cancer: A propensity score-matched study","volume":"13","author":"Chou","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2022.05.004_b0120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2022.05.004_b0125","series-title":"Analysis of longitudinal data","author":"Diggle","year":"1994"},{"key":"10.1016\/j.radonc.2022.05.004_b0130","series-title":"Applied regression analysis","author":"Draper","year":"1998"},{"key":"10.1016\/j.radonc.2022.05.004_b0135","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1214\/aos\/1176345976","article-title":"Cox's regression model for counting processes: A large sample study","volume":"10","author":"Andersen","year":"1982","journal-title":"Ann Stat"},{"key":"10.1016\/j.radonc.2022.05.004_b0140","series-title":"Modeling survival data: Extending the cox model","author":"Therneau","year":"2000"},{"key":"10.1016\/j.radonc.2022.05.004_b0145","series-title":"R: A language and environment for statistical computing","author":"Team RC","year":"2020"},{"key":"10.1016\/j.radonc.2022.05.004_b0150","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ijrobp.2006.05.064","article-title":"Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma","volume":"66","author":"Ma","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.004_b0155","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1038\/s41388-019-0749-y","article-title":"Mtorc2-mediated pdhe1\u03b1 nuclear translocation links ebv-lmp1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma","volume":"38","author":"Zhang","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.radonc.2022.05.004_b0160","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13046-019-1214-z","article-title":"The roles of glucose metabolic reprogramming in chemo- and radio-resistance","volume":"38","author":"Lin","year":"2019","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022002407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022002407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:21:53Z","timestamp":1759123313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814022002407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":32,"alternative-id":["S0167814022002407"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2022.05.004","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilization of the lymph node-to-primary tumor ratio of PET standardized uptake value and circulating Epstein\u2013Barr virus DNA to predict distant metastasis in nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2022.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}